Alta Sciences

OCTOBER 9, 2024

Since 2005, the PharmaVoice 100 has become one of the publication’s most anticipated features. Each winner represents progress toward a healthier future for everyone that is bolstered by science and technological advancements. Altasciences helps sponsors get better drugs to the people who need them, faster.

Clinical Pharmacology 40

Clinical Pharmacology Drug Development Science Clinical Trials 40

New Drug Approvals

APRIL 19, 2025

“Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias” Clinical Pharmacology and Therapeutics. Baker JG (February 2005). Atarashi H, Kuruma A, Yashima M, Saitoh H, Ino T, Endoh Y, et al. August 2000). 68 (2): 14350. doi : 10.1067/mcp.2000.108733.

FDA 62

FDA Clinical Trials Treatment Trials 62

Drug Target Review

NOVEMBER 27, 2024

Since 2005, he has played a vital role in ensuring that laboratory data meets rigorous quality standards and complies with industry regulations. Clinical Pharmacology & Therapeutics. Outsourcing Biomarkers in Clinical Trials: Advantages and Disadvantages. Available from: [link] Bakker E, Hendrikse NM, Ehmann F, et al.

Drug Development 52

Drug Development Regulations Laboratories FDA 52

New Drug Approvals

APRIL 18, 2025

2005, 46, 7179.In Article ] Rosati G: Clinical pharmacology of iomeprol. in ARKIVOC, 2006, 104 and Tetrahedron Lett., In a 50 mL three-necked round-bottomed flask equipped with a thermometer and a reflux condenser, solid 3,5-disubstituted phenol 1 (16.4 g, 50 mmol) was suspended in ethanol (30 mL). 2000 May;59(5):1169-86.

FDA 52

FDA Production FDA Approval Clinical Pharmacology 52